BioSpace News Archive

Drug Development

Soleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients

Amendment Lowers Minimum Age Inclusion Criteria to Four Years, from Eight Years, to Better Reflect Demographics of PWS Population

September 10, 2018
·
6 min read
Policy

CDC Awards BioCryst $35 Million RAPIVAB® Contract for Strategic National Stockpile

BioCryst Pharmaceuticals, Inc. today announced that the Centers for Disease Control and Prevention (CDC) has awarded BioCryst a $34.7 million contract for the procurement of up to 50,000 doses of BioCryst’s approved antiviral influenza therapy, RAPIVAB® (peramivir injection) over a five-year period.

September 10, 2018
·
3 min read
Business

SINGAPORE SCIENTIST AWARDED PRESTIGIOUS CIFAR AZRIELI GLOBAL SCHOLARSHIP

Dr Wan Yue joins international CIFAR research programme.

September 10, 2018
·
5 min read
Business

ThromboGenics Business Update – H1 2018

Positive Topline Results for Diabetic Eye Disease Portfolio

September 10, 2018
·
18 min read
Business

Vapourtec strengthens European presence with Analis deal

Flow chemistry engineering specialists Vapourtec have strengthened their presence across Europe with the signing of a distribution deal with Belgium-based Analis.

September 10, 2018
·
1 min read
Azeria Therapeutics, the world’s first pioneer factor drug discovery company, announces Series A investment from Sixth Element Capital

Azeria Therapeutics Limited today announced that it has successfully raised £4 million in Series A fundraising from the £70 million CRT Pioneer Fund, managed by Sixth Element Capital LLP (6EC), a UK based fund manager.

September 10, 2018
·
6 min read
Gestational diabetes may predispose to postpartum depression symptoms

Mothers diagnosed with gestational diabetes mellitus (GDM) have an elevated risk of developing postpartum depression symptoms, according to a new Finnish study.

September 10, 2018
·
2 min read
Business

Biom’up completes its Board of Directors with the nomination of Dr. Peter Byloos to support its international growth

Biom’up today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director.

September 10, 2018
·
4 min read
BioCapital

Sponsor and CRO Finalists Announced for 2018 SCRS Eagle Award

Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 SCRS Eagle Award™, selected from companies nominated by SCRS members.

September 10, 2018
·
1 min read
Drug Development

Zogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut Syndrome

67% of Patients Achieved At Least a 50% Reduction in Convulsive Seizures

September 10, 2018
·
6 min read